Assisted Reproductive Technologies: Methods and Advances
This paper examines the major developments and advancements in assisted reproductive technology (ART), providing an overview of six key methods available to infertile couples. The technologies covered include zygote intrafallopian transfer (ZIFT), donor egg or embryo use, surrogacy and gestational carriers, in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete intrafallopian transfer (GIFT). For each method, the paper describes the procedure, the conditions under which it is used, its benefits, and associated risks or limitations. The paper also briefly addresses the emotional and financial dimensions of ART and concludes with observations about future trends in reproductive medicine.
- Introduction to Assisted Reproductive Technology: Overview of ART and technologies to be examined
- Zygote Intrafallopian Transfer (ZIFT): Procedure combining IVF and fallopian tube placement
- Donor Egg or Embryo: Options and emotional considerations for egg or embryo donation
- Surrogacy and Gestational Carriers: Types of surrogacy and associated controversies
- In Vitro Fertilization (IVF): IVF steps, risks, costs, and success rate statistics
- Intracytoplasmic Sperm Injection (ICSI): Sperm injection technique for male-factor infertility
- Gamete Intrafallopian Transfer (GIFT): GIFT procedure and its pregnancy rate advantages
- Future Technologies and Conclusions: Trends in ART use and summary of findings
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Provides clear, organized coverage of six distinct ART methods, each in its own named section, making the paper easy to navigate and compare across technologies.
- Balances procedural description with clinical context — explaining not just how each technology works, but when it is indicated, what risks it carries, and how successful it has been.
- Incorporates both scholarly sources and institutional references (NIH, SART), lending credibility to statistical claims about success rates and medical risks.
Key academic technique demonstrated
The paper demonstrates effective use of synthesis across multiple sources to construct a comparative survey. Rather than simply summarizing one source per section, the author draws on books, encyclopedias, and health authority guidance to build a well-rounded description of each technology. This multi-source synthesis is particularly evident in the IVF section, where procedural detail from Burfoot (1999) is supplemented by NIH risk and cost data, giving readers a complete clinical picture.
Structure breakdown
The paper opens with a brief introduction that states the scope and lists the technologies to be covered. Each of the six ART methods then receives its own dedicated section, following a consistent pattern: definition, procedure steps, clinical indications, and risks or limitations. A short concluding section reflects on future trends and summarizes key findings. This predictable, parallel structure makes the paper easy to follow and well-suited for use as a reference overview.
Introduction to Assisted Reproductive Technology
Assisted reproductive technology has received a great deal of attention in recent years. Couples who have difficulty conceiving are now seeking out assisted reproductive technologies (ART) to have children. This paper examines the developments and advancements in assisted reproductive technologies, including zygote intrafallopian transfer (ZIFT), donor egg or embryo use, surrogacy and gestational carriers, in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete intrafallopian transfer (GIFT).
Zygote Intrafallopian Transfer (ZIFT)
According to Becker (2000), zygote intrafallopian transfer (ZIFT) is a form of reproductive technology that takes place after controlled ovarian hyperstimulation, oocyte retrieval, and in vitro fertilization. In this procedure, the zygote (the early embryo) is positioned in the fallopian tube through the use of laparoscopy. The purpose of ZIFT is to "combine the advantages of IVF-ET and GIFT by utilizing the fallopian tubes in their physiological role as the site of zygote transport, at the cost of subjecting the patient to two separate anesthesias" (Becker, 2000, p. 264).
According to the American Pregnancy Association, ZIFT is carried out using several steps. First, a woman's ovaries are stimulated with medications to increase the probability of producing multiple eggs (hyperstimulation). The eggs are then gathered via aspiration and fertilized in the same manner as in IVF. The fertilized eggs are then transmitted via a laparoscopic method: a catheter is positioned in the fallopian tube and the fertilized eggs are injected. The patient and physicians then wait to determine whether pregnancy has occurred.
Donor Egg or Embryo
In addition to the ZIFT procedure, donor eggs or embryos are also an option available to infertile couples (Tomlins, 2003). According to Tomlins (2003), eggs can be donated when a woman is unable to produce eggs, when there is a risk that a genetic disease will be passed on to the child, when the eggs a woman produces are not of sufficient quality, when the woman has undergone chemotherapy or other treatments that have rendered her eggs unviable, or when previous attempts at reproductive technologies have been unsuccessful.
In addition to egg donation, embryos can also be donated. In most cases, embryos are donated by couples who have undergone IVF and still have frozen embryos remaining. These couples can choose to donate their embryos, submit them for medical research, or have them destroyed. When embryos are donated, they are given to couples who have difficulty creating their own.
Tomlins (2003) also points out that relying on a donor egg can evoke significant emotions in a woman — emotions comparable to those a man may experience upon learning he is sterile. Using a donor egg or embryo also means the woman will have no genetic link to the child. For this reason, women are often advised to work through these feelings before proceeding with donor eggs or embryos.
Donor eggs are provided to couples through several channels:
Known donor: a donor who is known to the couple — often a sister, sister-in-law, or close friend (Tomlins, 2003).
Advertisement: the donor may be a woman who has responded to an advertisement placed by the couple (Tomlins, 2003).
Anonymous donor: a donor unknown to the couple, such as a woman who has donated eggs to a clinic anonymously (Tomlins, 2003).
References
Becker, G. (2000). The Elusive Embryo: How Women and Men Approach New Reproductive Technologies. Berkeley, CA: University of California Press.
Bleiklie, I., Goggin, M. L., & Rothmayr, C. (Eds.). (2003). Comparative Biomedical Policy: Governing Assisted Reproductive Technologies. London: Routledge.
Burfoot, A. (Ed.). (1999). Encyclopedia of Reproductive Technologies. Boulder, CO: Westview Press.
In Vitro Fertilization. National Institutes of Health. Retrieved from http://www.nlm.nih.gov/medlineplus/ency/article/007279.htm
Sloan, G. A. (1993). Postponing Parenthood: The Effect of Age on Reproductive Potential. New York: Insight Books.
Sparks, R. F. (2000). Sexual Health for Men: The Complete Guide. Cambridge, MA: Perseus Publishing.
Tomlins, J. (2003). The Infertility Handbook: A Guide to Making Babies. Crows Nest, N.S.W.: Allen & Unwin.
Zygote intrafallopian transfer: ZIFT. Retrieved from
Create your account
Always verify citation format against your institution’s current style guide requirements.